miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer.

导出 OA

翻译打印收藏纠错

第一作者： Jialu,Li

第一单位： Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, Tiyuanbei, Tianjin, 300060, China; Jiangsu Engineering Research Center for microRNA Biology and Biotechnology, State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, 210093, China.

作者： Jialu,Li ^[1] ; Hongwei,Liang ^[2] ; Ming,Bai ^[3] ; Tao,Ning ^[3] ; Cheng,Wang ^[4] ; Qian,Fan ^[1] ; Yanbo,Wang ^[2] ; Zheng,Fu ^[2] ; Nan,Wang ^[2] ; Rui,Liu ^[3] ; Ke,Zen ^[2] ; Chen-Yu,Zhang ^[2] ; Xi,Chen ^[2] ; Yi,Ba ^[2]

作者单位： Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, Tiyuanbei, Tianjin, 300060, China; Jiangsu Engineering Research Center for microRNA Biology and Biotechnology, State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, 210093, China. ^[1] Jiangsu Engineering Research Center for microRNA Biology and Biotechnology, State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, 210093, China. ^[2] Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, Tiyuanbei, Tianjin, 300060, China. ^[3] Jiangsu Engineering Research Center for microRNA Biology and Biotechnology, State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, 210093, China; Department of Clinical Laboratory, Jinling Hospital, Clinical School of Medical College, Nanjing University, Nanjing, China. ^[4]